The role of respiratory viruses in the pathogenesis of pediatric asthma

Pediatric Annals

Volumn 35, Issue 9, 2006, Pages 637-642

  Velissariou, Ioanna M ^a,b   Papadopoulos, Nikolaos G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BAFILOMYCIN A1; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ECHINACEA EXTRACT; ERYTHROMYCIN; MACROLIDE; RUPINTRIVIR; STEROID; ZINC;

ASTHMA; CLINICAL TRIAL; COMMON COLD; CORONAVIRUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPIDEMIC; HUMAN; IMMUNIZATION; IMMUNOMODULATION; PATHOGENESIS; PREVALENCE; PROPHYLAXIS; REVIEW; RHINOVIRUS; TREATMENT PLANNING; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

EID: 33749005095     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20060901-07     Document Type: Review

References (40)

1. McIntosh K, Ellis EF, Hoffman LS, et al. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr. 1973;82(4):578-590.
2. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis. 1980;122(4):567-575.
3. Papadopoulos NG, Hunter J, Sanderson G, Meyer J, Johnston SL. Rhinovirus identification by BgI I digestion of picornavirus RT-PCR amplicons. J Virol Methods. 1999;80(2): 179-185.
4. Xepapadaki P, Psarras S, Bossios A, et al. Human Metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol. 2004;30(3):267-270.
5. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-1260.
6. Johnston SL, Sanderson G, Pattermore PK, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1993;31(1):111-117.
7. Mallia P, Johnston SL. Respiratory viruses: do they protect from or induce asthma? Allergy. 2002;57(2):1118-1129.
8. Papadopoulos NG, Psarras S, Manoussakis E, Saxoni-Papageorgiou P. The role of respiratory viruses in the origin and exacerbations of asthma. Curr Opin Allergy Clin Immunol. 2003;3(1):39-44.
9. Sigurs N. Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res. 2002;3(Suppl 1):S8-S14.
10. Papadopoulos NG, Johnston SL. The role of viruses in the induction and progression of asthma. Curr Allergy Asthma Rep. 2001;1(2): 144-152.
11. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165(9):1285-1289.
12. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137-141.
13. Sigurs N, Bjarnason R, Sigurbergsson F, Kiellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501-1507.
14. Korppi M, Piippo-Savolainen E, Korhonen K, Remes S. Respiratory morbidity 20 years after respiratory syncytial virus infection in infancy. Pediatr Pulmonol. 2004;38(2):155-160.
15. Legg J, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute RSV bronchiolitis. Am J Res Crit Care Med. 2003;168(6):633-639.
16. Wenzel SE, Gibbs RL, Lehr MV, Simoes EA. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med. 2002;112(8):627-633.
17. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111(1):66-71.
18. Papadopoulos NG, Psarras S. Rhinoviruses in the pathogenesis of asthma. Curr Allergy Asthma Rep. 2003;3(2):137-145
19. Openshaw PJ, Hewitt C. Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma. Am J Respir Crit Care Med. 2000;162:S40-S43.
20. Illi S, von Mutius E, Lau S, et al, MAS Group. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ. 2001;322(7283):390-395.
21. McKeever TM, Lewis SA, Smith C, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol. 2002;109(1):43-50.
22. Celedon JC, Litonjua AA, Ryan L, Weiss ST, Gold DR. Day care attendance, respiratory tract illnesses, wheezing, asthma, and total serum IgE level in early childhood. Arch Pediatr Adolesc Med. 2002;156(3):241-245.
23. Bager P, Westergraard T, Rostgaard K, et al. Age at childhood infections and risk of atopy. Thorax. 2002;57(5):379-382.
24. Papadopoulos NG, Foteinos G. Is allergy a result or a modifier of viral infections?: an incoordination hypothesis. Allergy Clin Immunol Int. 2006; in press.
25. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995;310(6989):1225-1229.
26. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359(9309):831-834.
27. Slack-Smith LM, Read AW, Stanley FJ. Experience of respiratory and allergic illness in children attending childcare. Child Care Health Dev. 2002;28(2):171-177.
28. Papadopoulos NG, Papi A, Psarras S, Johnston SL. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev. 2004;5(3):255-260.
29. Mosser AG, Brockman-Schneider R, Amineva S, et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis. 2002;185(6):734-743.
30. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324(7340):763.
31. Xepapadaki P, Papadopoulos N, Bossios A, et al. Airway hyperresponsiveness in atopic and non-atopic asthmatic children following respiratory tract infections. Allergy. 2002;57: S295-S296.
32. Wilson NM. Virus infections, wheeze and asthma. Paediatr Respir Rev. 2003;4(3):184-192.
33. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162(4Pt 1):1403-1406.
34. Martinez FD, Stern DA, Wright AL, Taussig LM, Halopen M. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol. 1998;102(6Pt 1):915-920.
35. Yamaya M, Sasaki H. Rhinovirus and asthma. Viral Immunol. 2003;16(2):99-109.
36. Suzuki T, Yamaya M, Sekizawa K, et al. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am J Respir Crit Care Med. 2002;165(8): 1113-1118.
37. Ledford RM, Patel NR, Demenczuk TM, et al. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol. 2004;78(7):3663-3674.
38. Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother. 2003;47(12):3907-3916.
39. Grunberg K, Sharon RF, Sont JK, et al. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med. 2001;164(10Pt 1):1816-1822.
40. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005; 171(2):129-136.